What AI says about Lexeo Therapeutics

Lexeo Therapeutics focuses on developing genetic medicine candidates for cardiovascular diseases and APOE4-associated Alzheimer’s disease. The company builds on research from Weill Cornell Medicine and UC San Diego, partnering with leading institutions to advance gene therapy.